Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer

American Journal of Epidemiology

Volumn 169, Issue 8, 2009, Pages 990-995

  Wang, Na ^a   Zheng, Yingjie ^a   Yu, Xinsen ^b   Lin, Wenyao ^b   Chen, Yue ^c   Jiang, Qingwu ^a  

^a FUDAN UNIVERSITY   (China)

^b Haimen City Center for Disease Control and Prevention   (China)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

China; Cohort studies; Hepatitis B virus; Liver neoplasms; Mortality; Risk factors; Sex

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANTIGEN; C3 PLANT; CANCER; COHORT ANALYSIS; HEALTH RISK; INFECTIOUS DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; VIRAL DISEASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CHINA; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; AGE; COMORBIDITY; DRINKING BEHAVIOR; HETEROZYGOTE; LIVER CELL CARCINOMA; LIVER TUMOR; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; SEX RATIO; SMOKING;

ASIA; CHINA; EURASIA; FAR EAST; HAIMEN; JIANGSU;

HEPATITIS B VIRUS;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; CHINA; COMORBIDITY; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK ASSESSMENT; SEX DISTRIBUTION; SEX FACTORS; SMOKING;

EID: 63649137176     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn418     Document Type: Article

References (25)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2(9):533-543.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-2576.
3. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol. 2007;13(1):74-81.
4. Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127(5 suppl 1):S5-S16.
5. Evans AA, Chen G, Ross EA, et al. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev. 2002;11(4):369-376.
6. Rothman KJ. Epidemiology: An Introduction. Oxford, NY: Oxford University Press; 2002.
7. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia, PA: Lippincott-Raven; 1998.
8. Kalilani L, Atashili J. Measuring additive interaction using odds ratios [electronic article]. Epidemiol Perspect Innov. 2006;3:5.
9. Andersson T, Alfredsson L, Källberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 2005; 20(7):575-579.
10. Assmann SF, Hosmer DW, Lemeshow S, et al. Confidence intervals for measures of interaction. Epidemiology. 1996;7(3): 286-290.
11. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17(3):227-236.
12. Yu MW, Chang HC, Chang SC, et al. Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology. 2003;38(6):1393-1400.
13. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834): 121-124.
14. Lawrence T, Hageman T, Balkwill F. Cancer: sex, cytokines, and cancer. Science. 2007;317(5834):51-52.
15. Wang Y, Cui F, Lv Y, et al. HBs Ag and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology. 2004;39(2):318-324.
16. Yu MW, Yang YC, Yang SY, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst. 2001;93(21):1644-1651.
17. Sung YM, Tang NL, Lai PB, et al. Re: Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men [letter]. J Natl Cancer Inst. 2003;95(7):559-560.
18. Prieto J. Inflammation, hepatocellular carcinoma and sex: IL-6 in the centre of the triangle. J Hepatol. 2008;48(2): 380-381.
19. Wands J. Hepatocellular carcinoma and sex. N Engl J Med. 2007;357(19):1974-1976.
20. Shimizu I, Kohno N, Tamaki K, et al. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol. 2007;13(32): 4295-4305.
21. Vivekanandan P, Kannangai R, Ray SC, et al. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis. 2008;46(8): 1227-1236.
22. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2(8):479-486.
23. Chemin I, Trépo C. Clinical impact of occult HBV infections. J Clin Virol. 2005;34(suppl 1):S15-S21.
24. Marrero CR, Marrero JA. Viral hepatitis and hepatocellular carcinoma. Arch Med Res. 2007;38(6):612-620.
25. Zhang HW, Yin JH, Li YT, et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut. 2008;57(12):1713-20.